secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2026-08-06T20:13:52+00:00
Accession:  0001006837-26-000061
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q2 net income $10.4M vs loss; revenue up 74% to $421.6M; DBMG record quarter
--------------------------------------------------------------------------------

- Revenue $421.6M (+74.2% YoY); diluted EPS $0.71 vs ($1.67); Total Adj. EBITDA $46.3M (+194.9%).
- Infrastructure (DBMG) revenue $414.0M (+77.6%), net income $26.4M, Adj. EBITDA $48.7M; adjusted backlog $2.7B.
- Broadcasting refinanced with $105M loan; INNOVATE agreed to sell ~75% stake to CONX, retaining ~25%.
- Life Sciences: MediBeacon engaged with 100+ institutions; R2 revenue $2.2M, opex cut 50% YoY.
- Pursuing asset dispositions including sale of DBMG assets/equity and majority of Broadcasting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000061/0001006837-26-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000061/vate-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001006837-26-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer